TABLE 2.

The form of cancer treatment of various NMOFs as phototherapeutic agents for cancer therapy.

NMOFs	Photosensitizers (PSs)	Light source	Therapeutic agents	Form of cancer treatment	Refs
PB@MIL-100(Fe)	Prussian blue (PB)	NIR		PTT	Wang B et al. (2016)
PB@mSiO2−PEG	Prussian blue (PB)	NIR	DOX	PTT	Su et al. (2016)
UiO-66@PAN	Polymer polyaniline (PAN)	NIR	-	PTT	Wang D et al. (2016)
PPy@MIL-100	Polypyrrole (PPy)	NIR	-	PTT and chemotherapy	Chen D et al. (2017)
MOF@HA@ICG	Indocyanine green (ICG)	NIR	-	PTT	Cai et al. (2017)
Hf6(μ 3-O)4 (μ 3-OH)4 (DBP)6	Porphyrin DBP	Visible light	1O2	PDT	Lu et al. (2014)
Hf6(μ 3-O)4 (μ 3-OH)4 (DBP)6	Porphyrin DBC	Visible light	1O2	PDT	Lu et al. (2015)
Hf-TCPP	Hf4+, Porphyrin	X-ray	1O2	PDT and RT	Liu et al. (2016)
PCN-224	Zr4+, Porphyrin	UV	1O2	PDT	Park et al. (2016a)
Zn-TCPP-BPDTE	Porphyrin TCPP	UV	1O2	PDT	Park et al. (2015)
UiO-66	TCPP	UV	1O2	PDT	Park et al. (2016b)
UiO-PDT	BODIPYs	Confocal laser	1O2	PDT	Wang et al. (2016a)
Hf-/Zr-based MOFs	[M6]-clusters (M = Hf or Zr)	X-ray, visible light	photons	PDT	Wang et al. (2014)
Hf-BPY-Ir/Ru	Hf atoms	X-ray	1O2	PDT	Lan et al. (2017)
IDOi@TBC-Hf	Hf atoms	LED	1O2 and IDOi	PDT and immunotherapy	Lu Y et al. (2016)
DBP-Hf	Hf atoms	LED	1O2 and IDOi	PDT and immunotherapy	Lu et al. (2018a)
g-C3N4@ZIF-8	g-C3N4	-	1O2 and IDOi	PDT and immunotherapy	Chen et al. (2015)
PCN-222	Porphyrin	-	1O2 and DOX	PDT and immunotherapy	Liu et al. (2017)
MIL-88B	Porphyrin	-	MB and DOX	PDT and chemotherapy	Sharma et al. (2017)
F127-MnO2-ZIF@DOX/C3N4	g-C3N4	NIR	1O2 and DOX	PDT and immunotherapy	Zhang Q et al. (2018)